Fleitman J S, Bruni J, Perrin J H, Wilder B J
J Clin Pharmacol. 1980 Aug-Sep;20(8-9):514-7. doi: 10.1002/j.1552-4604.1980.tb02544.x.
In vitro equilibrium dialysis experiments show that salicylate and phenylbutazone displace valproate from its binding sites on human serum albumin at therapeutic concentrations, whereas warfarin and carbamazepin do not.
体外平衡透析实验表明,在治疗浓度下,水杨酸盐和保泰松会将丙戊酸盐从其在人血清白蛋白上的结合位点置换出来,而华法林和卡马西平则不会。